Oxamniquine

CAS No. 21738-42-1

Oxamniquine ( —— )

Catalog No. M21872 CAS No. 21738-42-1

Oxamniquine is a potent agent for the treatment of schistosomiasis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1143 Get Quote
50MG 2322 Get Quote
100MG 3060 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Oxamniquine
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxamniquine is a potent agent for the treatment of schistosomiasis.
  • Description
    Oxamniquine is a potent agent for the treatment of schistosomiasis.
  • In Vitro
    Oxamniquine is a potent agent for the treatment of schistosomiasis.
  • In Vivo
    Oxamniquine (500 mg/kg) alone or Oxamniquine (250 mg/kg) in combination with praziquantel reduces the mortality of infected snails compared to the control group.
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21738-42-1
  • Formula Weight
    279.33
  • Molecular Formula
    C??H??N?O?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCC1=C([N+]([O-])=O)C=C2C(CCC(CNC(C)C)N2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mattos AC, et al. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni. Acta Trop. 2007 May;102(2):84-91.
molnova catalog
related products
  • N-(2-Hydroxypropyl)m...

    N-(2-Hydroxypropyl)methacrylamide is used in the synthesis of copolymers for the targeted delivery of antileishmanial agents in Visceral leishmaniasis.

  • YCN47284

    YCN47284 is an antimalarial compound with an IC50 of 1 μM for P. falciparum.

  • Naphthoquine phospha...

    An antimalarial drug.